about
Panniculitis, due to Mycobacterium smegmatis, in two Finnish cats.Pyogranulomatous panniculitis in a cat associated with infection by the Mycobacterium fortuitum/peregrinum groupVeterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice -- the operation of a spontaneous reporting scheme in a European Union country -- the UK, and schemes in other countries.Veterinary pharmacovigilance. Part 6. Predictability of adverse reactions in animals from laboratory toxicology studies.Photosensitisation induced by clofazimine in a cat.Treatment of corneal ulcers: what are the medical options?Haemoplasmas: lessons learnt from cats.Update in feline therapeutics: clinical use of 10 emerging therapies.Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.Eye examination in the cat: Step-by-step approach and common findings.Blindness now attributed to enrofloxacin therapy in a previously reported case of a cat with acromegaly treated by cryohypophysectomy.In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine.Diagnostic ophthalmology. Retinal degenerationContralateral optic neuropathy and retinopathy associated with visual and afferent pupillomotor dysfunction following enucleation in six cats.Opportunistic mycobacterial granuloma in a cat associated with a member of the Mycobacterium terrae complex.Ocular manifestation of disseminated Mycobacterium simiae infection in a cat.Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.Ofloxacin-associated retinopathy in rabbits: role of oxidative stress.Comparison of two sedation protocols for short electroretinography in cats.Lower respiratory tract infections in cats: 21 cases (1995-2000).The prevalence of ocular lesions associated with hypertension in a population of geriatric cats in Auckland, New Zealand.Bacteraemia in 66 cats and antimicrobial susceptibility of the isolates (1995–2004)
P2860
Q30764053-DB6EDE15-60BF-4FD3-B760-191831059CCDQ36083679-5DBC8FAA-6202-41CA-9F60-2099EECAD005Q36103055-B484456C-9640-4102-8E44-F56C43F5E8E3Q36103068-5D9911A3-F6FA-4740-8941-4E9FA46C4296Q36924439-B0573081-CCD6-4BC6-82D5-95A33D5DC1F5Q37736870-A2351C50-862B-4387-AEB2-E3EF09036727Q38086295-9A54367C-9982-4B00-A363-2EB224F96414Q38363411-28EA879F-729B-4F8F-AF83-317F9F33DD04Q38427273-9B9DA954-77D6-4CD5-8AC6-A3D171147112Q38937618-092B98F6-1013-48F4-B42F-2660FE3CD2A1Q40557999-405132D0-4970-41A3-9ABE-696967BCA097Q41521496-E2FA640A-FBC6-498D-A74C-2F5276D459F2Q42793840-7BF54EB1-ADD3-4CC9-858D-3CC912C48AB3Q43494092-00A1F472-CCF3-4747-A793-9CB86AF14675Q44290960-83F2F49A-1322-438A-951F-1FBCB73AAFA8Q44373245-F2F64ABD-D037-4A9A-972C-0977F6B36A48Q44930646-4B7EA9C5-8D49-4135-8A00-1D61D7663441Q46420052-920E8FCE-4AC2-4397-8216-0AE3C6FBDA27Q47803398-C9594746-004B-436D-910F-DCA1C60737F7Q47983164-D37B2604-8A7C-4CCB-AEA3-B7D2938AC6CCQ54731409-5F7ECCF4-A1CE-4302-908D-4D013ED0F369Q58206883-FBAB4E65-B24C-4943-BCED-9D071AA6B0A7
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Enrofloxacin-associated retinal degeneration in cats.
@en
Enrofloxacin-associated retinal degeneration in cats.
@nl
type
label
Enrofloxacin-associated retinal degeneration in cats.
@en
Enrofloxacin-associated retinal degeneration in cats.
@nl
prefLabel
Enrofloxacin-associated retinal degeneration in cats.
@en
Enrofloxacin-associated retinal degeneration in cats.
@nl
P2093
P1476
Enrofloxacin-associated retinal degeneration in cats.
@en
P2093
Ketring KL
van der Woerdt A
P304
P356
10.1046/J.1463-5224.2001.00182.X
P577
2001-06-01T00:00:00Z